News Focus
News Focus
Followers 42
Posts 9206
Boards Moderated 2
Alias Born 09/06/2014

Re: Franken-vestor post# 9413

Tuesday, 09/25/2018 6:59:59 PM

Tuesday, September 25, 2018 6:59:59 PM

Post# of 15906
All of Gene's PR's have been shooting blanks since the FDA rejection in 2014. It's pretty obvious that there are never going to be significant sales in Turkey or India or Africa or anywhere else. It's all been hype. Especially about Turkey.

Gene has no funding and I believe these poorer countries don't WANT to diagnose cervical cancer because they don't want to pay for treatment. Women are not equal to men in those countries. Sad but true.

The only hope for the Luviva Scan is the USA and I just don't see GTHP ever pulling that off. Not Gene's fault. The FDA killed this company in 2014. It's a zombie now. Zombies can stagger along for years and that's what GTHP is doing.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News